Correlation Between Bristol Myers and MedPeerInc

Can any of the company-specific risk be diversified away by investing in both Bristol Myers and MedPeerInc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and MedPeerInc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bristol Myers Squibb and MedPeerInc, you can compare the effects of market volatilities on Bristol Myers and MedPeerInc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of MedPeerInc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and MedPeerInc.

Diversification Opportunities for Bristol Myers and MedPeerInc

-0.2

Correlation Coefficient

Bristol Myers  MedPeerInc

Good diversification

The 3 months correlation between Bristol and MedPeerInc is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and MedPeerInc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MedPeerInc and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with MedPeerInc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MedPeerInc has no effect on the direction of Bristol Myers i.e., Bristol Myers and MedPeerInc go up and down completely randomly.

Pair Corralation between Bristol Myers and MedPeerInc

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 0.67 times more return on investment than MedPeerInc. However, Bristol Myers Squibb is 1.49 times less risky than MedPeerInc. It trades about 0.11 of its potential returns per unit of risk. MedPeerInc is currently generating about -0.15 per unit of risk. If you would invest  5,038  in Bristol Myers Squibb on September 24, 2024 and sell it today you would earn a total of  720.00  from holding Bristol Myers Squibb or generate 14.29% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Bristol Myers Squibb  vs.  MedPeerInc

Bristol Myers Squibb

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

MedPeerInc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MedPeerInc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Bristol Myers and MedPeerInc

The main advantage of trading using opposite Bristol Myers and MedPeerInc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, MedPeerInc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MedPeerInc will offset losses from the drop in MedPeerInc's long position.

The idea behind Bristol Myers Squibb and MedPeerInc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.